An open-label trial of risperidone in children with autism

Diler R., Firat S., Avci A.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, cilt.63, sa.1, ss.91-102, 2002 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 63 Sayı: 1
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1016/s0011-393x(02)80009-1
  • Dergi Adı: CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.91-102
  • Anahtar Kelimeler: child, autism, pervasive developmental disorders, risperidone, PERVASIVE DEVELOPMENTAL DISORDER, ATYPICAL NEUROLEPTICS, YOUNG-CHILDREN, ADOLESCENTS, SCHIZOPHRENIA
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background: Risperidone has potent effects on serotonin and dopamine neuronal systems, both of which have been implicated in the pathophysiology of autism .Risperidone is increasingly being used to treat specific symptoms in children with autism.